S D Katz

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Core Evid 2:225-31. 2008
  2. ncbi request reprint Potential role of statins in the treatment of heart failure
    Stuart D Katz
    Yale Heart Failure and Transplant Center, Yale University School of Medicine, New Haven, CT, USA
    Curr Atheroscler Rep 10:318-23. 2008
  3. ncbi request reprint Blood volume assessment in the diagnosis and treatment of chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Med Sci 334:47-52. 2007
  4. ncbi request reprint Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Ste 301, New Haven, CT 06510, USA
    Circulation 111:310-4. 2005
  5. ncbi request reprint Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure
    Stuart D Katz
    Department of Internal Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 95:36-42. 2005
  6. ncbi request reprint Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, Section of Cardiovascular Medicine, Heart Failure Center, New Haven, Conn 06510, USA
    J Nucl Cardiol 9:215-25. 2002
  7. ncbi request reprint Mechanisms and treatment of anemia in chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, 135 College Street, Suite 301, New Haven, CT 06510, USA
    Congest Heart Fail 10:243-7. 2004
  8. ncbi request reprint Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure
    S D Katz
    Yale University School of Medicine, Heart Failure Center, Yale University, 135 College Street, Suite 201, New Haven, CT 06510, USA
    Congest Heart Fail 9:9-15. 2003
  9. ncbi request reprint Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure
    Ana Silvia Androne
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut, USA
    Am J Cardiol 97:685-9. 2006
  10. pmc Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
    H Zheng
    Department of Medicine, Yale University School of Medicine, New Haven, Conneticut 06510, USA
    Kidney Int 69:679-84. 2006

Research Grants

  1. Studies on Genetics in Heart Failure
    Stuart Katz; Fiscal Year: 2007

Collaborators

  • Donna Mancini
  • Ritchard G Cable
  • John D Parker
  • Alan J Bank
  • X Huang
  • Hao Wang
  • Ulrich Jorde
  • Paolo C Colombo
  • Chim C Lang
  • Milton Packer
  • Shunichi Homma
  • Mathew S Maurer
  • L Lund
  • Sumit Verma
  • Katarzyna Hryniewicz
  • Haoyi Zheng
  • Ana Silvia Androne
  • Yi da Tang
  • Alhakam Hudaihed
  • Clarito Dimayuga
  • Dmitry Abramov
  • Milan Patel
  • H Zheng
  • Milan D Patel
  • Forrester A Lee
  • Artyom Sedrakyan
  • Marc Klapholz
  • Shrikanth P Y Upadya
  • Karin Nystrom
  • Clara Saldarriaga
  • Shrikanth Upadya
  • John Lamanca
  • A S Androne
  • Timothy J Vittorio
  • Rose S Cohen
  • Henry M Rinder
  • Lawrence Young
  • Q Zhang
  • Aleksandr Yasskiy
  • Ghazanfar Qureshi
  • Krzysztof Jankowski
  • Nancy Votto
  • Bryan Spencer
  • Edward J Brown
  • Thierry H Le Jemtel
  • Jill Kalman
  • Robert A Phillips
  • Judith Mitchell
  • Janis Bozzo
  • April M Lowe
  • Frank Messineo
  • Khashayar Sehhat
  • Nikita Varshneya
  • Robert Moskowitz
  • Marrick Kukin
  • Rachel Bijou
  • Anita Soni
  • Lynn A Sleeper
  • Richard Steingart
  • Robert Berkowitz
  • Jay S Meisner
  • R Goldsmith
  • K Hryniewicz
  • A Arwady

Detail Information

Publications34

  1. pmc Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Core Evid 2:225-31. 2008
    ..The long elimination half-life of tadalafil makes it suitable for once-daily dosing...
  2. ncbi request reprint Potential role of statins in the treatment of heart failure
    Stuart D Katz
    Yale Heart Failure and Transplant Center, Yale University School of Medicine, New Haven, CT, USA
    Curr Atheroscler Rep 10:318-23. 2008
    ..Until further information becomes available, routine use of statins is not recommended in the heart failure population...
  3. ncbi request reprint Blood volume assessment in the diagnosis and treatment of chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Med Sci 334:47-52. 2007
    ..Additional work is needed to determine the clinical utility of serial blood volume measurements in the management of patients with CHF...
  4. ncbi request reprint Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Ste 301, New Haven, CT 06510, USA
    Circulation 111:310-4. 2005
    ..Endothelial function is known to be impaired in subjects with chronic heart failure (CHF), but the association between endothelial function and subsequent mortality risk in CHF has not been previously reported...
  5. ncbi request reprint Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure
    Stuart D Katz
    Department of Internal Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 95:36-42. 2005
    ..The incidence of events related to cardiovascular effects was low. Sildenafil is an effective and well-tolerated management of ED in men who have mild to moderate CHF...
  6. ncbi request reprint Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, Section of Cardiovascular Medicine, Heart Failure Center, New Haven, Conn 06510, USA
    J Nucl Cardiol 9:215-25. 2002
  7. ncbi request reprint Mechanisms and treatment of anemia in chronic heart failure
    Stuart D Katz
    Yale University School of Medicine, 135 College Street, Suite 301, New Haven, CT 06510, USA
    Congest Heart Fail 10:243-7. 2004
    ..Additional studies are needed to determine the safety and efficacy of long-term erythropoietic therapy in chronic HF patients...
  8. ncbi request reprint Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure
    S D Katz
    Yale University School of Medicine, Heart Failure Center, Yale University, 135 College Street, Suite 201, New Haven, CT 06510, USA
    Congest Heart Fail 9:9-15. 2003
    ..Further studies are warranted to characterize the safety and efficacy of type 5 phosphodiesterase inhibition in the treatment of chronic heart failure...
  9. ncbi request reprint Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure
    Ana Silvia Androne
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut, USA
    Am J Cardiol 97:685-9. 2006
    ..Impaired vasodilation may contribute to differences in therapeutic response and clinical outcomes in African-American patients with chronic HF...
  10. pmc Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects
    H Zheng
    Department of Medicine, Yale University School of Medicine, New Haven, Conneticut 06510, USA
    Kidney Int 69:679-84. 2006
    ..This potential mechanistic link between intravenous iron and endothelial dysfunction warrants further study of cardiovascular effects of intravenous iron in anemic chronic kidney disease populations...
  11. ncbi request reprint Inhibition of angiotensin-converting enzyme and phosphodiesterase type 5 improves endothelial function in heart failure
    Katarzyna Hryniewicz
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, U S A
    Clin Sci (Lond) 108:331-8. 2005
    ..Therefore further work to characterize chronic effects of combined ACE and PDE5 inhibition on endothelial function are warranted...
  12. ncbi request reprint Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension
    Milan D Patel
    Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA
    Am J Cardiol 96:47M-51M. 2005
    ..Additional studies are needed to determine the therapeutic potential of this class of agents in these disease states...
  13. ncbi request reprint Iron stores and vascular function in voluntary blood donors
    Haoyi Zheng
    Department of Internal Medicine, Yale University School of Medicine, 135 College St, Suite 301, New Haven, CT 06510, USA
    Arterioscler Thromb Vasc Biol 25:1577-83. 2005
    ..We sought to assess the effects of blood donation frequency on body iron stores and physiological and biochemical biomarkers of vascular function associated with atherosclerosis progression...
  14. pmc Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure
    A S Androne
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Heart 89:854-8. 2003
    ..To characterise the effects of acetylcholinesterase inhibition with pyridostigmine on parasympathetic tone in patients with chronic heart failure (CHF)...
  15. ncbi request reprint Treatment of anemia in patients with chronic heart failure
    Stuart D Katz
    Department of Internal Medicine, Yale University College of Medicine, New Haven, CT 06510, USA
    J Card Fail 10:S13-6. 2004
    ..Additional studies are needed to determine the safety and efficacy of long-term erythropoietic therapy in CHF patients...
  16. ncbi request reprint Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure
    Katarzyna Hryniewicz
    Department of Internal Medicine, Yale University College of Medicine, New Haven, Connecticut 06510, USA
    J Card Fail 9:464-8. 2003
    ..The effects of beta-adrenergic receptor blocker (BB) therapy on body weight in cachectic and noncachectic subjects with CHF has not been previously reported...
  17. ncbi request reprint Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes
    Ana Silvia Androne
    Department of Internal Medicine, Yale University School of Medicine, 135 College Street, New Haven, CT 06510, USA
    Am J Cardiol 93:1254-9. 2004
    ..13 to 6.19, p = 0.025). These findings demonstrate that clinically unrecognized hypervolemia is frequently present in nonedematous patients with CHF and is associated with increased cardiac filling pressures and worse patient outcomes...
  18. ncbi request reprint Insulin sensitivity, vascular function, and iron stores in voluntary blood donors
    Haoyi Zheng
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, 135 College St, New Haven, CT 06510, USA
    Diabetes Care 30:2685-9. 2007
    ..We sought to determine whether iron-dependent changes in glucose metabolism may contribute to improved vascular function in blood donors...
  19. ncbi request reprint Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial
    Yi da Tang
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Am Heart J 154:494.e1-7. 2007
    ..Whether prothrombotic effects of rHuEpo mitigate the effects of antiplatelet agents used in acute coronary syndrome patients is unknown...
  20. ncbi request reprint Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options
    Yi da Tang
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Circulation 113:2454-61. 2006
  21. doi request reprint The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes
    Yi da Tang
    Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    Heart Fail Rev 13:387-92. 2008
    ..These data provide the rationale for interventional treatment trials to determine if anemia is in the causal pathway for disease progression and increased mortality risk in HF patients...
  22. ncbi request reprint Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure
    Shrikanth Upadya
    Yale University School of Medicine, Department of Internal Medicine, New Haven, Connecticut 06510, USA
    J Heart Lung Transplant 23:466-72. 2004
    ..The clinical use of positive inotropic therapy at home in patients awaiting cardiac transplantation has not been reported since United Network for Organ Sharing (UNOS) regulations were changed to allow home infusions in Status 1B patients...
  23. ncbi request reprint Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation
    Shrikanth P Y Upadya
    Yale University School of Medicine, Department of Internal Medicine, Section of Cardiovascular Medicine, New Haven, Connecticut 06510, USA
    J Card Fail 10:384-9. 2004
    ..A detailed comparative cost analysis of this outpatient strategy versus in-hospital care has not been previously reported...
  24. ncbi request reprint Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure
    Ulrich P Jorde
    Division of Circulatory Physiology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Circulation 106:1055-7. 2002
    ..We simultaneously measured plasma aldosterone levels and the degree of inhibition of the vascular converting enzyme in patients with CHF...
  25. ncbi request reprint Association of extended work shifts, vascular function, and inflammatory markers in internal medicine residents: a randomized crossover trial
    Haoyi Zheng
    JAMA 296:1049-50. 2006
  26. ncbi request reprint Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects
    Haoyi Zheng
    Department of Medicine, Peking Union Medical College Hospital, Beijing, China
    Arterioscler Thromb Vasc Biol 22:E15-8. 2002
    ..We hypothesized that the antioxidant effects of dexrazoxane would prevent homocysteine-induced endothelial dysfunction in the brachial artery of normal human subjects...
  27. ncbi request reprint Hemodilution is common in patients with advanced heart failure
    Ana Silvia Androne
    Department of Medicine, Columbia University, New York, NY, USA
    Circulation 107:226-9. 2003
    ..A low hematocrit may result from an increased plasma volume (hemodilution) or from reduced red blood cell volume (true anemia). The prevalence and clinical outcome of CHF patients with hemodilution is unknown...
  28. ncbi request reprint Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure
    Ulrich P Jorde
    Division of Cardiology, New York University School of Medicine, New York, New York, USA
    Am J Cardiol 94:1501-5. 2004
    ....
  29. ncbi request reprint Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure
    Donna M Mancini
    Department of Medicine, Columbia Presbyterian Medical Center, New York, NY, USA
    Circulation 107:294-9. 2003
    ..An increase in hemoglobin could enhance exercise performance by increasing oxygen delivery. We investigated the effect of erythropoietin (EPO) on exercise performance in anemic patients with CHF...
  30. ncbi request reprint Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure
    Katarzyna Hryniewicz
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Circulation 108:971-6. 2003
    ..We hypothesized that alpha-adrenergic-blocking effects of carvedilol would limit vasoconstriction in response to adrenergic stimuli when compared with metoprolol...
  31. ncbi request reprint Dissociation between exercise hemodynamics and exercise capacity in patients with chronic heart failure and marked increase in ejection fraction after treatment with beta-adrenergic receptor antagonists
    Mathew Maurer
    Division of Circulatory Physiology, Columbia Presbyterian Medical Center, New York, New York, USA
    Am J Cardiol 91:356-60. 2003
  32. ncbi request reprint Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers
    Timothy J Vittorio
    Division of Circulatory Physiology, Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Circulation 107:290-3. 2003
    ..Accordingly, we compared the vasopressor response to infused Ang II in patients treated with carvedilol and metoprolol, a selective beta-antagonist...
  33. ncbi request reprint Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry
    Marc Klapholz
    Saint Vincent Catholic Medical Centers, New York, New York, USA
    J Am Coll Cardiol 43:1432-8. 2004
    ....
  34. pmc Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions
    Dmitry Abramov
    Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 102:1069-72. 2008
    ....

Research Grants1

  1. Studies on Genetics in Heart Failure
    Stuart Katz; Fiscal Year: 2007
    ..The proposed studies will advance applicant career development and provide new insight into pathophysiology of CHF. ..